跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,838 条关于
“Tru Niagen”
全部
1,838
临床试验
1,014
药物
503
机构
87
资讯
234
2个月前
Niagen Bioscience Launches NB4168, a Proprietary NAD+ Precursor, as First Pharmaceutical Candidate for Ataxia Telangiectasia
4年前
ChromaDex Strengthens Patent Portfolio with Two New Continuation Patents for Nicotinamide Riboside Manufacturing
8个月前
Niagen Bioscience Acquires Core NAD+ Patent Portfolio from Queen's University Belfast
去年
Niagen Bioscience Secures Exclusive License for Nicotinamide Riboside as Parkinson's Disease Therapy
去年
First Clinical Trial Shows Nicotinamide Riboside Improves Multiple Health Outcomes in Werner Syndrome Patients
前天
Vera's Trutakna Stabilizes eGFR and Cuts IgAN Progression Risk 76% in Final ORIGIN 3 Analysis
去年
QIAGEN Expands Molecular Biology Portfolio with SABiosciences Acquisition
去年
QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel Receives FDA Clearance for Rapid Diagnostics
去年
QIAGEN Unveils Advanced Cancer Genomic Profiling Tools at AACR 2025
去年
Anti-Tau Antibodies Show Promise in Targeting Alzheimer's Disease Pathologies
第 1 页,共 24 页
上一页
下一页